<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Chlorthalidone</id>
	<title>Chlorthalidone - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Chlorthalidone"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Chlorthalidone&amp;action=history"/>
	<updated>2026-05-28T12:58:22Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Chlorthalidone&amp;diff=6806&amp;oldid=prev</id>
		<title>MDElliottMD: home-claude category backfill (parser-claude gap closure)</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Chlorthalidone&amp;diff=6806&amp;oldid=prev"/>
		<updated>2026-05-23T10:43:34Z</updated>

		<summary type="html">&lt;p&gt;home-claude category backfill (parser-claude gap closure)&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 10:43, 23 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l21&quot;&gt;Line 21:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 21:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== References ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Thiazide-like diuretics]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Category:Antihypertensives]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Chlorthalidone&amp;diff=5932&amp;oldid=prev</id>
		<title>MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #124</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Chlorthalidone&amp;diff=5932&amp;oldid=prev"/>
		<updated>2026-05-23T03:51:55Z</updated>

		<summary type="html">&lt;p&gt;parser-claude batch MedTemplate pre-fill, Top 300 #124&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{MedTemplate&lt;br /&gt;
| generic           = Chlorthalidone&lt;br /&gt;
| brand             = Thalitone; mostly prescribed generically&lt;br /&gt;
| structure         =&lt;br /&gt;
| classes           = [[:Category:Thiazide-like_diuretics|Thiazide-like diuretic]], [[:Category:Antihypertensives|Antihypertensive]]&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;hypertension-use&amp;quot;&amp;gt;Hypertension&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;edema-use&amp;quot;&amp;gt;Edema&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;nephrogenic-di-use&amp;quot;&amp;gt;Nephrogenic diabetes insipidus&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = 12.5-25 mg PO once daily; titrate to 50 mg&lt;br /&gt;
| preparations      = 15 mg, 25 mg, 50 mg tablets&lt;br /&gt;
| fda_max           = 100 mg/d (rarely used)&lt;br /&gt;
| pill_id           =&lt;br /&gt;
| routes            = Oral&lt;br /&gt;
| onset             = Diuresis at 2-3 hours; BP effect over weeks&lt;br /&gt;
| duration          = 48-72 hours per dose (much longer than hydrochlorothiazide)&lt;br /&gt;
| halflife          = 40-60 hours (notable for the thiazide class)&amp;lt;ref name=&amp;quot;thalitone-label&amp;quot;&amp;gt;FDA Prescribing Information, chlorthalidone tablets, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012109s015lbl.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
| bioavailability   = ~65% (oral)&amp;lt;ref name=&amp;quot;thalitone-label&amp;quot; /&amp;gt;&lt;br /&gt;
| pregnancy         = Avoided where possible; same class concerns as HCTZ.{{citation needed}}&lt;br /&gt;
| legal             = [[USLegal:Prescription only|Rx-only]] in US&lt;br /&gt;
| mechanism         = &amp;lt;vote slug=&amp;quot;chlorthalidone-mech-claim&amp;quot;&amp;gt;Chlorthalidone inhibits the Na+/Cl- cotransporter (NCC) in the distal convoluted tubule, producing the same natriuretic and vasodilatory effects as hydrochlorothiazide but with a substantially longer half-life that yields more sustained 24-hour BP control and modest evidence of better cardiovascular outcomes (ALLHAT, SHEP).&amp;lt;/vote&amp;gt; Despite the favorable trial data, hydrochlorothiazide remains the dominant US thiazide prescription due to pricing and habit. Hyponatremia, hypokalemia, hypomagnesemia, hyperuricemia, hyperglycemia, and erectile dysfunction are characteristic class effects&amp;lt;ref name=&amp;quot;thalitone-label&amp;quot; /&amp;gt;.&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>